We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295

Top Buys

Rank Stock Value
1
JWSM
Jaws Mustang Acquisition Corp.
JWSM
+$52.5M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29.9M
3
AAC
Ares Acquisition Corporation
AAC
+$29.8M
4
FCAX
Fortress Capital Acquisition Corp.
FCAX
+$21.5M
5
SVFA
SVF Investment Corp. Class A Ordinary Shares
SVFA
+$21M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$187M
2
AVLR
Avalara, Inc.
AVLR
+$149M
3
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$112M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$96.2M
5
ZEN
ZENDESK INC
ZEN
+$91M

Sector Composition

Rank Sector Weight
1 Financials 69.3%
2 Technology 10.26%
3 Industrials 8.47%
4 Healthcare 5.73%
5 Real Estate 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROSE
101
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
$14.6M 0.38%
1,411,936
+443,134
+46% +$4.54M
WPCA
102
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$14M 0.36%
1,382,516
+670,684
+94% +$6.71M
VCXB
103
DELISTED
10X Capital Venture Acquisition Corp III
VCXB
$13.9M 0.36%
1,350,269
+75,229
+6% +$767K
DCRD
104
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
$13.5M 0.35%
1,321,702
+503,449
+62% +$5.1M
IBER
105
DELISTED
Ibere Pharmaceuticals
IBER
$13.4M 0.35%
1,330,102
+243,601
+22% +$2.44M
EBAC
106
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$12.7M 0.33%
1,254,733
+259,259
+26% +$2.59M
PLAO
107
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$12.7M 0.33%
1,225,316
+479
+0% +$4.92K
ASCB
108
DELISTED
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
$12.6M 0.33%
1,229,868
-3,556
-0.3% -$35.9K
AFTR
109
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
$12.5M 0.32%
1,244,984
+19,346
+2% +$192K
CPTK
110
DELISTED
Crown PropTech Acquisitions
CPTK
$12.5M 0.32%
1,231,847
+596,979
+94% +$5.98M
BNFT
111
DELISTED
Benefitfocus, Inc.
BNFT
$12M 0.31%
+1,146,220
New +$10.3M
MRT icon
112
Marti Technologies
MRT
$150M
$11.9M 0.31%
1,165,874
+1,008,831
+642% +$10.2M
GIAC
113
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
$11.5M 0.3%
1,130,000
+387,425
+52% +$3.92M
AFAR
114
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
$11.4M 0.29%
1,107,007
– –
MACA
115
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
$11.3M 0.29%
1,125,817
+683,517
+155% +$6.84M
ACDI
116
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
$11.2M 0.29%
1,085,293
+3,914
+0.4% +$40K
GTAC
117
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$11M 0.28%
1,065,367
+123,530
+13% +$1.26M
ZEO
118
Zeo Energy
ZEO
$18.4M
$10.7M 0.28%
1,032,456
+302,416
+41% +$3.1M
TETE
119
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
$10.7M 0.28%
1,036,929
+43,956
+4% +$449K
EVGR
120
DELISTED
Evergreen Corporation Class A Ordinary Share
EVGR
$10.6M 0.27%
1,030,424
+60,836
+6% +$619K
PHYT
121
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$10.5M 0.27%
1,013,447
+16,888
+2% +$173K
WEL
122
DELISTED
Integrated Wellness Acquisition Corp
WEL
$10.5M 0.27%
1,013,760
+224,053
+28% +$2.29M
AVAC
123
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$10.3M 0.27%
999,985
+993,900
+16,334% +$10M
ZURA icon
124
Zura Bio
ZURA
$526M
$10.2M 0.26%
999,980
+423,433
+73% +$4.29M
GOGN
125
DELISTED
GoGreen Investments Corporation
GOGN
$9.6M 0.25%
924,671
+94,762
+11% +$972K
3 4
5
6 7

Similar funds

GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.